HelloType1 Digital Education Platform for Individuals With Type 1 Diabetes in Southeast Asia: Data Analytics Study
Background: Type 1 diabetes remains an underrecognized and challenging condition across Southeast Asia, where many countries face limited health care infrastructure, shortages of trained health care professionals, inconsistent access to diabetes education, and a lack of culturally appropriate resources in local languages. These barriers contribute to delayed diagnosis, suboptimal self-management, high rates of diabetic ketoacidosis, and inequities in care. During the COVID-19 pandemic, Action4Diabetes, a nonprofit organization working with local health care professionals and diabetes associations across Southeast Asia, developed HelloType1, a multilingual digital educational platform designed to improve awareness, education, and access to credible type 1 diabetes information. The platform was launched sequentially in Cambodia in 2021, Vietnam and Thailand in 2022, and Malaysia in 2023 through formal memorandums of understanding with local partners. Objective: This study aimed to evaluate the reach, platform usage, and online engagement of the HelloType1 digital educational platform across Southeast Asia between 2021 and 2024. Methods: Website analytics from Google Analytics 4 and Meta Business Suite metrics were descriptively analyzed to assess digital reach and engagement across countries. Metrics were compared over time and by country to examine patterns of platform uptake and user engagement. Results: HelloType1 demonstrated substantial growth between 2021 and 2024. Total unique website users increased from 1178 in 2021 to 40,361 in 2024, representing a marked expansion in regional reach. Pageviews rose from 4644 in 2021 to 83,689 in 2024, suggesting increasing content use and user platform engagement. By 2024, most website visits originated from organic search engines. Platform use was predominantly mobile-based, particularly in Vietnam, Thailand, and Malaysia, with the strongest engagement among adults aged 25 to 54 years. Facebook followers increased from 940 to 4553, and average engagement rates rose between 2022 and 2024. Cambodia achieved the highest number of Facebook interactions, whereas Thailand demonstrated the highest engagement rate. Content-level analysis showed that practical self-management topics, including blood glucose monitoring, insulin treatment, nutrition and exercise, complications, and emotional support, generated high levels of reach and interaction. Conclusions: HelloType1 demonstrates strong growth, mobile-first use, search-driven visibility, and engagement with practical self-management content. These findings support the feasibility and potential utility of a low-cost, multilingual digital education model, while future studies should evaluate its effects on knowledge, behavior, and clinical outcomes.
<img src="https://jmir-production.s3.us-east-2.amazonaws.com/thumbs/f42cc3a2c711eb52cb2e1acd2a3dd461" />
Investigating the Potential Effects of Medical AI Systems on Physician Autonomy: Pretest of a Semistructured Qualitative Interview Guide
Background: AI is an increasingly prominent feature of contemporary health care, with medical AI systems beginning to support diagnostic and therapeutic processes in many clinical domains. Alongside the anticipated benefits of these technologies, their introduction also raises broader questions about how clinical work and professional roles may change. In particular, medical AI systems may affect physician autonomy, a key factor influencing the acceptance and long-term implementation of new medical technologies. Objective: The aim of this study was to develop and pretest a semistructured interview guide concerning the potential effects of medical AI systems on physician autonomy. Methods: The interview guide was theoretically grounded in a 7-component model of physician autonomy proposed by Schulz and Harrison. Semistructured qualitative interviews were conducted with a sample of 7 hospital physicians. Interview recordings were transcribed and analyzed using a hybrid inductive-deductive thematic approach: themes were first identified inductively from participant responses and subsequently mapped onto the 7-component model of physician autonomy proposed by Schulz and Harrison. Data were analyzed to assess both the potential effects of medical AI systems on physician autonomy and the methodological adequacy of the interview guide. Results: Most participants did not express strong concerns about losing clinical autonomy through the introduction of AI systems. However, several autonomy-related risks were identified, including potential deskilling, automation bias, limited system explainability, and increasing economic or cost-related pressures. Participants emphasized that AI should serve as a supportive tool rather than a substitute for physician judgment. All physicians agreed that AI systems should not replace clinicians as primary clinical decision-makers. Conclusions: Medical AI was largely viewed as compatible with physician autonomy; however, participants highlighted important risks that warrant attention in future research and system design. Our preliminary findings suggest that autonomy-related concerns extend beyond the direct loss of decision-making authority and include broader professional, cognitive, and organizational dimensions. However, our inductively identified themes and subthemes did not fully reflect all components of physician autonomy, indicating the need for further refinement of how to assess physician autonomy in qualitative research.
<img src="https://jmir-production.s3.us-east-2.amazonaws.com/thumbs/863e0d120aa4d3458824761f49d8ac04" />
Sweet Caroline: BCIs That Restore Sensation of Touch Show Long-Term Safety
“Touching hands, reaching out, touching me, touching you.”
The lead up to the chorus of Neil Diamond’s “Sweet Caroline” has become a ritual in stadiums and bars across America, celebrating one of the most universal human experiences: reaching out to touch another person.
For people living with paralysis after a spinal cord injury, that experience often disappears. Damage to the spinal cord not only interrupts movement but also severs the flow of sensory information from much of the body, leaving many unable to feel touch below the site of their injury.
While brain-computer interfaces (BCIs) already restore a measure of independence by translating thoughts into movement, allowing people to control robotic limbs, computers, and other assistive devices, they have long lacked something fundamental: touch. Now researchers report the strongest evidence yet that restoring artificial touch can be done safely over the long term.
In a study published in Science Translational Medicine, scientists followed five people with cervical spinal cord injuries who received tiny electrical pulses directly to the brain’s somatosensory cortex for periods ranging from nearly three years to a decade. Across more than 173 million stimulation pulses delivered over a combined 27 years of implanted use, the researchers found no serious stimulation-related adverse events while consistently restoring sensations of touch to participants’ hands.
One participant in the study described the difference after researchers restored an artificial sense of touch by stimulating his brain.

Instead of merely watching a hand grasp another person’s hand, he said, it felt as though he were shaking it himself. “It’s the difference between ‘I told a robotic arm to shake your hand’ and ‘I am shaking your hand,’” Charles Greenspon, PhD, assistant professor of neurological surgery at the University of Chicago and the study’s lead author, told Inside Precision Medicine. “That degree of embodiment is completely impossible without sensory feedback because you just don’t believe it’s yours.”
Creating touch
That sense of ownership—of a prosthetic becoming part of the body—is one of the biggest remaining challenges in neurotechnology. Companies including Neuralink, Precision Neuroscience, and Paradromics have largely focused on reading signals from the brain. Today’s most advanced BCIs excel at reading neural activity, decoding a person’s intentions to move a robotic arm or computer cursor. But they are largely one-way systems, sending nothing back to the brain.
Without sensory feedback, users must rely almost entirely on vision, making movements slower, less natural, and more mentally demanding. Restoring sensation by writing information back into the nervous system has remained a much greater challenge—not because the concept is new, but because evidence that repeated brain stimulation is safe over many years has been limited.
Although involving only five participants, the study is the largest and longest safety evaluation of intracortical microstimulation in humans. The findings address a major obstacle to the next generation of BCIs: proving that the brain can safely receive artificial sensory information over many years. If confirmed in larger clinical trials, the work could accelerate the development of truly bidirectional BCIs that both decode a person’s intentions and restore the sensory feedback that makes movement feel natural.
The researchers’ approach bypasses the damaged spinal cord entirely. Participants received two tiny microelectrode arrays implanted in the region of the somatosensory cortex responsible for hand sensation. Brief electrical pulses delivered through individual electrodes produced sensations that participants perceived as coming from specific locations on their hands.
“Once that device is in, we deliver tiny electrical pulses to the brain directly, and that creates the sensations,” Greenspon said. “The brain cannot functionally tell the difference between something that occurs at your hand and travels up your arm to the brain or directly stimulates the brain.”
Built to last
The researchers also wanted to know whether the implants would continue working after years of repeated use. Like any implanted medical device, microelectrode arrays gradually degrade.
The results suggest repeated stimulation does not accelerate that process. Detection thresholds increased only gradually, and even after a decade, about 60% of the electrodes in one participant could still reliably evoke touch sensations, while about two-thirds remained functional throughout the study. Researchers also found no relationship between how heavily individual electrodes were used and how quickly they deteriorated. “No company is claiming that these implants last forever,” Greenspon said. “It’s the same as a knee replacement.”
The study’s primary goal was straightforward: determine whether years of repeated stimulation would trigger seizures, damage brain tissue, or accelerate deterioration of the implanted electrodes. Across 623 hours of stimulation, participants experienced no seizures and no serious adverse events related to the stimulation itself.
Researchers also found no evidence that the electrical pulses damaged participants’ remaining natural sensation. The only stimulation-related side effects consisted of 53 brief episodes of lingering tingling or buzzing after stimulation ended, most resolving within seconds. “It’s one of the few times where you want a null result,” Greenspon said. “We just wanted to say, ‘Look, we didn’t find anything bad.’”
That absence of problems may ultimately be the study’s most important finding, providing the evidence regulators and device developers need before sensory feedback can become a standard feature of future BCIs.
Closing the brain’s feedback loop
For people who may eventually rely on BCIs outside the laboratory, restoring touch could prove just as important as restoring movement. Without sensory feedback, every movement requires constant visual attention. Greenspon compares the experience to leaving the dentist after a local anesthetic: “You can speak perfectly… It’s because you don’t know where your tongue is.”
Artificial touch changes something more subtle as well. Rather than operating a machine, users begin to experience a prosthetic as part of themselves. Researchers believe that sense of embodiment could make future prosthetic limbs not only more dexterous but also less mentally exhausting to use.
The next major challenge is restoring proprioception—the internal sense that tells us where our limbs are without looking. Current sensory BCIs cannot reproduce that ability. Researchers also hope future systems will deliver richer sensory information, allowing users to distinguish whether an object is soft or hard, rough or smooth, or beginning to slip from their grasp.
The findings arrive as brain-computer interfaces transition from academic laboratories to commercial development. Before sensory neuroprostheses become routine treatments, researchers will still need to conduct larger clinical studies.
For decades, BCI research has focused on teaching machines to understand the brain. The next generation may depend just as much on teaching the brain to understand the machine. If that happens, the most important advance may not be giving people the ability to control a prosthetic hand. It may be giving them the feeling that the hand is their own.
That is what made the participant’s handshake remarkable. The breakthrough wasn’t that a hand closed around another person’s. It was that, for the first time, it felt like their own handshake.
The post Sweet Caroline: BCIs That Restore Sensation of Touch Show Long-Term Safety appeared first on Inside Precision Medicine.
STAT+: GOP blocks effort to end Medicare test of AI prior authorization
WASHINGTON — A Senate vote to halt a Medicare pilot that uses artificial intelligence to approve or deny care failed along party lines on Thursday.
Republicans voted to block consideration of a Democratic-led measure, which would have stopped the Trump administration from employing prior authorization in original Medicare, where the practice is rarely allowed. The vote was 46 to 50.
The White House had pushed back against the Democratic bill. Medicare officials gave a handout to lawmakers’ offices on Tuesday outlining what they say are the benefits of the test, known as WISeR.
AI-Designed Synthetic CRISPR-Like Nucleases Show Activity in Cells
A new paper published in Science describes using artificial intelligence (AI) to design functional synthetic RNA-guided nucleases whose activity matches or exceeds that of natural enzymes. In the paper, titled “Structure and evolution-guided design of minimal RNA-guided nucleases,” the scientists wrote that the results “establish a strategy for creating non-natural RNA-guided nucleases and conformationally active nucleic acid binders, enlarging the designable protein space.”
The team includes scientists from Innovative Genomics Institute and the California Institute for Quantitative Bioscience, both at the University of California, Berkeley, and collaborators at other institutions.The findings highlight AI’s ability to expand the CRISPR toolbox to include RNA-guided nucleases with novel properties beyond those found in nature. It is a task that has been challenging for protein design methods because of the complexity of multi-domain proteins, “whose activity depends on coordinated RNA and DNA recognition, activation, and cleavage by distinct conformational states,” the scientists wrote. As such, seemingly small changes can disrupt enzyme activity.
Sequence-based biological language models have been used to successfully design new nucleases by inferring sequence-function relationships, but they often produce versions of these proteins that closely resemble the reference sequences used to train them. Meanwhile, structure-guided rational design approaches, which “offer a robust strategy to sample highly divergent protein sequences” as well as “structures not found in nature” have been used to generate things like dynamic switches and DNA binders. However, designing complex proteins like RNA-guided nucleases with multiple functional domains and conformations has remained challenging for these methods.
In the Science paper, the scientists present an alternate strategy for generating novel functional proteins that combines the ESM Inverse Folding (ESM-IF1) model with evolution-informed residue constraints. As a test case, they used it to generate new variants for TnpB, a family of CRISPR-cas12-like nucleases that mediate RNA-guided DNA cleavage and regulate transcription among other tasks. Members of this enzyme family are “an attractive target for protein design because they couple programmable DNA targeting and a variety of natural functions to a minimal architecture,” the scientists explained in the paper.
The results showed that compared to sequence-based biological language models which generated proteins with binding domains with over 99% identity to natural homology, their approach created “DNA- and RNA-interacting lobes with AI-generated contacts that had 83% and 72% identity to their closest counterparts in nature.”
As part of the study, the scientists screened the activity of the designed proteins, dubbed SynTnpBs, first in the bacterial cells and then selected the most active ones for further testing in plant and human cells. They also used cryo-electron microscopy to determine the structures of the most divergent variants. Their analysis showed that many AI-designed nucleases either retained or surpassed the activity of natural TnpB in multiple cell types. Microscopy studies further revealed that the engineered proteins formed new electrostatic and hydrogen-bonding networks that stabilize interactions at the RNA-DNA interface across different conformations.
The post AI-Designed Synthetic CRISPR-Like Nucleases Show Activity in Cells appeared first on GEN – Genetic Engineering and Biotechnology News.
STAT+: Despite earnings celebration, UnitedHealth signals more financial pain for employers
UnitedHealth Group smashed through investors’ earnings expectations in the second quarter, with executives confidently saying this new level of profit is durable for the foreseeable future.
The numbers lifted the company’s stock about 3% as it attempts to return to financial dominance under CEO Stephen Hemsley. But a string of comments made during the company’s earnings call on Thursday signals a more ominous path ahead for America’s businesses and workers.
More than 150 million Americans get their health coverage from a job. A new series from STAT chronicles how the costs of that insurance are stretching employers like never before. An increasing number of America’s small businesses are abandoning traditional health benefits completely, forcing workers to find alternative options.
Pete Hegseth’s announcement of annual testosterone screenings for service members divides medical experts
Medical experts are divided on Defense Secretary Pete Hegseth’s announcement that U.S. service members will undergo testosterone deficiency screenings with their annual physical exams.
“War fighters aged 30 and older are going to be tested annually as part of their periodic health assessment,” said Hegseth in a video, posted with the caption “The High-T Department of War.” Elective testosterone testing will be available to younger service members, too, and if recommended, testosterone replacement therapy would be at the individual’s discretion.

